Literature DB >> 16876247

Natural antibody mediated innate autoimmune response.

Ming Zhang1, Michael C Carroll.   

Abstract

Recent advance in autoimmunity research reveals that the innate immune system is able to recognize self-targets and initiate inflammatory response in a similar way as with pathogens. This review describes one novel example of this innate autoimmunity, ischemia-reperfusion (I/R) injury. Studies of intestinal, skeletal muscle, and heart I/R models showed that reperfusion of ischemic tissues elicits an acute inflammatory response involving serum complement system which is activated by natural IgM. The recent identification of a monoclonal natural IgM that initiates I/R led to the identification of non-muscle myosin heavy chain type II A and C as the self-targets in two different tissues. New evidence further suggests that IgM binds initially to ischemic antigen providing a binding site for mannan binding lectin (MBL) which subsequently leads to activation of complement and results in tissue injury. Therefore, natural IgM mediated innate autoimmunity is likely responsible for the detrimental consequences in ischemic diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876247     DOI: 10.1016/j.molimm.2006.06.022

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  28 in total

1.  Asbestos activates CH12.LX B-lymphocytes via macrophage signaling.

Authors:  Devon L Rasmussen; Jean C Pfau
Journal:  J Immunotoxicol       Date:  2011-12-01       Impact factor: 3.000

2.  CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent.

Authors:  Keith M Woods; Michael R Pope; Sara M Hoffman; Sherry D Fleming
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

3.  Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function.

Authors:  P Thompson; I R Badell; M Lowe; J Cano; M Song; F Leopardi; J Avila; R Ruhil; E Strobert; G Korbutt; G Rayat; R Rajotte; N Iwakoshi; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2011-08-29       Impact factor: 8.086

Review 4.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

5.  Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury.

Authors:  Haekyung Lee; Danielle J Green; Lawrence Lai; Yunfang Joan Hou; Jens C Jensenius; David Liu; Cheolho Cheong; Chae Gyu Park; Ming Zhang
Journal:  Mol Immunol       Date:  2009-12-09       Impact factor: 4.407

6.  Intestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemia/reperfusion.

Authors:  Byron L Sparkes; Emily E Archer Slone; Mary Roth; Ruth Welti; Sherry D Fleming
Journal:  Biochim Biophys Acta       Date:  2010-01-18

7.  Human natural IgM can induce ischemia/reperfusion injury in a murine intestinal model.

Authors:  Ming Zhang; Elisabeth M Alicot; Michael C Carroll
Journal:  Mol Immunol       Date:  2008-07-30       Impact factor: 4.407

8.  Restoration of skeletal muscle ischemia-reperfusion injury in humanized immunodeficient mice.

Authors:  Eric G Sheu; Sean M Oakes; Cyrus Ahmadi-Yazdi; Jalil Afnan; Michael C Carroll; Francis D Moore
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

9.  Allograft outcomes in outbred mice.

Authors:  D K Reichenbach; Q Li; R A Hoffman; A L Williams; W D Shlomchik; D M Rothstein; A J Demetris; F G Lakkis
Journal:  Am J Transplant       Date:  2013-01-11       Impact factor: 8.086

10.  Delineating the relationships among the formation of reactive oxygen species, cell membrane instability and innate autoimmunity in intestinal reperfusion injury.

Authors:  Haekyung Lee; Eun Hee Ko; Mark Lai; Na Wei; Javi Balroop; Zerin Kashem; Ming Zhang
Journal:  Mol Immunol       Date:  2013-12-22       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.